Respiratory Infections

During the spring COVID-19 outbreak, an examination of Swiss people in Geneva shows only a small amount of the population with IgG antibodies.

Findings show states who followed stay-at-home orders indeed flattened their curves. Now what?

Analysis projects significant toll from virus, even with some measures in place.

Trending infectious disease news.

A Harvard Medical School study team sought to identify individuals at elevated risk for severe COVID-19 and, among them, those at high risk of financial ruin as a result of costs associated with their care.

Infectious disease experts have recommended that stockpiles of several promising vaccine candidates be created as they enter late stage development.

A brief on today's top ID stories.

Baloxavir marboxil showed superiority over placebo and similar efficacy to oseltamir in reducing influenza symptoms.

A summary of the latest infectious disease news.

COVIDSeq is a qualitative test for the detection of SARS-CoV-2 RNA.

Investigators from the Universitat Autònoma de Barcelona have identified links between antibiotic resistant S maltophilia phenotypes and "quorum sensing."

ChromaCode now intends to use its own multiplexing technology to help launch a COVID-19 assay later this year. The assay would combine multiple respiratory viruses into a single test in anticipation of the upcoming flu season.

Patrick Soon-Shiong, MD, describes goals and expectations for the accelerated coronavirus vaccine program Operation Warp Speed.

Early administration of such therapies in this patient group not shown to help mortality rates.

A brief update on today's infectious disease news.

The test uses whole blood, plasma, or serum. The testing kit is intended to produce reliable results within 10 minutes.

Patrick Soon-Shiong, MD, explains why an ImmunityBio SARS-CoV-2 vaccine candidate uses Nucleocapsid DNA alongside Spike DNA.

An assessment of 21 pediatric cases leads France investigators to believe development is due to post-viral immunological reactions.

Mild symptoms may still present high risk for SARS-CoV-2 transmission.

A quick brief on today's top infectious disease news.

Due to health concerns, the US FDA is reissuing some EUAs to clarify which respirators are suited for decontamination and reuse.

SARS-CoV-2 arrived in Northern California through a complicated series of introductions internationally and between states.

Mary Schmidt, MD, discusses challenges in translating infectious disease advice to policy action.

Pinar Karaca-Mandic, PhD, explains new research showing how exponentional rates of hospitalizations were avoided in 4 shut-down states.

Jason Pogue, PharmD, BCPS, BCIDP, speaks about the state of publishing during the COVID-19 pandemic.